Oct 18, 2018 - Centene's (CNC) third quarter should exhibit strong performances by its Government-backed and Medicaid businesses.
Oct 17, 2018 - EyePoint (EYPT) gains an FDA approval for its eye therapy Yutiq to help cure chronic non-infectious uveitis affecting the posterior segment of the eye.
Oct 17, 2018 - Allergan (AGN) is facing loss of exclusivity for many blockbuster products. However, drugs like Botox/Linzess, new drugs and cost cuts can shield it from potential sales drop.
Oct 15, 2018 - Big pharma drug makers and biotech continued to top the healthcare sector by broker targets. WallStars are distinguished by positive broker target price upsides.The Healthcare sector is comprised of 1
Oct 09, 2018 - VistaGen is a clinical-stage biopharmaceutical company developing treatments to fight depression and other central nervous system illnesses.With a large target market size and candidates at Phase 2 of
Oct 03, 2018 - Allergan generates increasing revenues.Its NASH franchise is also progressing satisfactorily with the AURORA Phase 3 NASH trial interim data readout anticipated H1/2019.Clinically, cenicriviroc has sh
Oct 03, 2018 - Paratek (PRTK) gets FDA approval for Nuzyra for the treatment of serious community-acquired bacterial infections and Seysara for the treatment of acne.
Sep 28, 2018 - FDA grants approval to Lilly's (LLY) Emgality for migraine and Pfizer's (PFE) Vizimpro for an advanced lung cancer indication. Novartis (NVS) to cut more than 2,000 jobs in Switzerland and U.K
Sep 27, 2018 -
Sep 27, 2018 - Eton Pharmaceuticals has filed proposed terms to sell $18 million in common stock in an IPO.The firm is attempting to reformulate existing, approved treatments to reduce costs and improve patient adhe